DOCSLIB.ORG

Chemical Composition, Antimicrobial and Antiparasitic Screening of the Essential Oil from Phania Matricarioides (Spreng.) Griseb

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chemical Composition, Antimicrobial and Antiparasitic Screening of the Essential Oil from Phania Matricarioides (Spreng.) Griseb molecules Article Chemical Composition, Antimicrobial and Antiparasitic Screening of the Essential Oil from Phania matricarioides (Spreng.) Griseb. Yamilet I. Gutiérrez 1, Ramón Scull 1, Anabel Villa 2, Prabodh Satyal 3, Paul Cos 4,5, Lianet Monzote 5,6,* and William N. Setzer 3,5,7,* 1 Department of Pharmacy, Institute of Pharmacy and Food, Havana University, Coronela, Lisa, Havana 13600, Cuba; [email protected] (Y.I.G.); [email protected] (R.S.) 2 Genetic toxicology and antitumor laboratory, Drug Research and Development Center (CIDEM), Havana 10600, Cuba; [email protected] 3 Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT 84043, USA; [email protected] 4 Laboratory for Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, 2610 Wilrijk, Belgium; [email protected] 5 Research Network Natural Products against Neglected Diseases (ResNet NPND) 6 Parasitology Department, Center of Research, Diagnostic and Reference, Institute of Tropical Medicine “Pedro Kouri”, Havana 10400, Cuba 7 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA * Correspondence: [email protected] (L.M.); [email protected] or [email protected] (W.N.S.); Tel./Fax: +53-7-255-3612 (L.M.); +1-256-824-6519 (W.N.S.) Academic Editors: Valeria Patricia Sülsen and Albertina Moglioni Received: 3 April 2019; Accepted: 22 April 2019; Published: 24 April 2019 Abstract: Essential oils (EOs) have gained increasing attention due to their pharmacological effectiveness, and they also constitute some of the most popular natural products. In this study, we present the chemical characterization of the EO from Phania matricarioides and the in vitro activity/selectivity against a wide panel of bacteria, fungi and parasitic protozoa. Forty-five compounds were identified in the studied EO, of which lavandulyl acetate (40.1%) and thymyl isobutyrate (13.9%) were the major components. The EO did not inhibit bacterial or fungal growth at the maximum concentration tested (64 µg/mL), although it displayed activity on all evaluated protozoa (IC50 values ranging from 2.2 to 56.6 µg/mL). In parallel, the EO demonstrated a noteworthy cytotoxic activity against peritoneal macrophages (CC50 values of 28.0 µg/mL). The most sensitive microorganism was Trypanosoma cruzi, which had a superior activity (IC50 = 2.2 µg/mL) and selectivity (SI = 13) in respect to other parasitic protozoa and the reference drug (p < 0.05). Further in vivo studies are needed to evaluate the potential use of this EO and the main compounds as antitrypanosomal agents. To our knowledge, this is the first report of chemical characterization and antimicrobial assessment of the EO from P. matricarioides. Keywords: Phania matricarioides; essential oil; antimicrobial screening; cytotoxicity; Trypanosoma cruzi 1. Introduction Indiscriminate and irrational use of antimicrobial agents has created an unprecedented challenge for human civilization due to the microbes’ development of antimicrobial resistance. Complementary and alternative medicines (CAMs) are used by 60–80% of developing countries, as they are one of the most prevalent sources of medicine worldwide. In recent years, research on plant-based drugs has increased tremendously, and there is some hope seen in certain medicinal plants that have immense potential to combat bacterial, fungal, protozoal and viral diseases with Molecules 2019, 24, 1615; doi:10.3390/molecules24081615 www.mdpi.com/journal/molecules Molecules 2019, 24, x FOR PEER REVIEW 2 of 11 plant-based drugs has increased tremendously, and there is some hope seen in certain medicinal Moleculesplants that2019 ,have24, 1615 immense potential to combat bacterial, fungal, protozoal and viral diseases 2with of 11 safety. Such plant metabolites include quinones, alkaloids, lectins, polypeptides, flavones, flavonoids, flavonols, coumarins, terpenoids, phenylpropanoids and tannins [1,2]. In particular, safety.other plant Such-derived plant metabolites natural products, include quinones,such as essential alkaloids, oils lectins, (EOs) polypeptides,, have experienced flavones, an upsurge flavonoids, in flavonols,attention due coumarins, to their terpenoids, efficacious phenylpropanoids bioactivities [3], andand tannins represent [1,2 ].one In particular,of the most other popular plant-derived natural naturalproduct products,classes due such to astheir essential applications oils (EOs), in dermatology, have experienced cosmetics an upsurge and aromatherapy in attention due [4] to. There their ehavefficacious been bioactivitiesnumerous [publications3], and represent regarding one of thethe most utility popular of EOs natural as productantimicrobial, classes dueanticancer, to their applicationsanti-inflammatory in dermatology, and antiviral cosmetics agents. and In aromatherapy recent years, [4numerous]. There have papers been reporting numerous antimicrobial publications regardingproperties theof EOs utility extracted of EOs asfrom antimicrobial, higher plants anticancer, have been anti-inflammatory published, including and antiviral antibacterial, agents. Inantifungal recent years, and antiparasitic numerous papers activities reporting [5]. antimicrobial properties of EOs extracted from higher plantsRecently, have been we published, have focused including on Phania antibacterial, matricarioides antifungal (Spreng.) and Griseb. antiparasitic (Figure activities 1) (Asteraceae [5]. or CompositaeRecently, family), we have which focused has been on Phania traditionally matricarioides used for(Spreng.) digestive Griseb. conditions (Figure (stomach1) (Asteraceae pain, bad ordigestion Compositae and diarrhea) family), and which dermatological has been traditionally lesions [6,7] used. P. matricarioides for digestive is conditions included (stomachin a very large pain, badand digestionwidespread and family diarrhea) of flowering and dermatological plants that lesions grow [ 6for,7]. ornamentalP. matricarioides purposesis included [8], but in a the very family large andalso widespreadrepresents a familycertain of economic flowering importance plants that due grow to forthe ornamental provision of purposes products [8 such], but as the cooking family oils, also representslettuce, sunflower a certain seeds, economic artichokes, importance sweetenin due to theg agents, provision coffee of products substitutes such and as cooking herbal oils,teas lettuce,[9]. In sunfloweraddition, many seeds, species artichokes, possess sweetening medicinal agents, properties, coffee including substitutes antioxidant and herbal [10] teas, antiparasitic [9]. In addition, [11], manyanticancer species [12] possess and medicinal hepatoprotective properties, including[13]. In antioxidant particular, [10 ], antiparasiticthe antidiarrheal, [11], anticancer analgesic, [12] andanti- hepatoprotectiveinflammatory and [13 anti]. In-oxidant particular, effects the antidiarrheal, of extracts have analgesic, been demonstrated anti-inflammatory and andcorrelated anti-oxidant with esomeffects active of extracts common have phytochemicals been demonstrated such and ascorrelated phenolic withcompounds, some active tannins, common flavonoids, phytochemicals lactonic suchcompounds, as phenolic triterpenes compounds, or steroids, tannins, terpenes flavonoids, and organic lactonic acids compounds, [6,14,15]. Howeve triterpenesr, as or far steroids, as we terpenesknow, the and EO organic from acidsP. matricarioides [6,14,15]. However, has not as been far as chemically we know, the characterized EO from P. matricarioides, and its biologicalhas not beenproperties chemically have not characterized, been scientifically and its biologicaldemonstrated. properties have not been scientifically demonstrated. In this study, takingtaking intointo accountaccount thethe antimicrobialantimicrobial potential of EOs,EOs, we have chemically characterizedcharacterized of the EO from P. matricarioidesmatricarioides and screenedscreened forfor potentialpotential activityactivity/selectivity/selectivity against bacteria, fungi and parasitic protozoa of medicalmedical relevance.relevance. Figure 1. Phania matricarioidesmatricarioidesin in a a natural natural habitat. habitat. Picture Picture taken taken by by the the authors authors during during collection collection of the of plantthe plant (March (March 2013, 2013, Bauta Bauta municipality, municipality, Artemisa, Artemisa, Cuba). Cuba). 2. Results The obtained volatile oil from P. matricarioides was colorless and aromatic, and yielded 0.1 0.002%. The obtained volatile oil from P. matricarioides was colorless and aromatic, and yielded± 0.1 ± The0.002%. results The of theresults gas chromatography–massof the gas chromatography spectrometry–mass (GCspectrome/MS) aretry summarized (GC/MS) are in Table summarized1, and show in thatTable the 1, chemicaland show composition that the chemical of the EOcomposition was made of up the of EO 48 compounds, was made up of of which 48 compounds, 45 components of which were identified,45 components representing were identified, 98.9% of therepresenting total oil. The98.9% predominant of the total components oil. The predominant were lavandulyl components acetate (40.1%),were lavandulyl followed acetate by thymyl (40.1%) isobutyrate, followed (13.9%) by thymyl (Table isobutyrate1 and Figure (13.9%)2). (Table 1 and Figure 2). The EOEO diddid not not exhibit exhibit bacterial bacterial or fungalor fungal growth growth inhibition inhibition at the at maximum
Load more

Recommended publications
  • Chapter 12 Antimicrobial Therapy Antibiotics
    Chapter 12 Antimicrobial Therapy Topics: • Ideal drug - Antimicrobial Therapy - Selective Toxicity • Terminology - Survey of Antimicrobial Drug • Antibiotics - Microbial Drug Resistance - Drug and Host Interaction An ideal antimicrobic: Chemotherapy is the use of any chemical - soluble in body fluids, agent in the treatment of disease. - selectively toxic , - nonallergenic, A chemotherapeutic agent or drug is any - reasonable half life (maintained at a chemical agent used in medical practice. constant therapeutic concentration) An antibiotic agent is usually considered to - unlikely to elicit resistance, be a chemical substance made by a - has a long shelf life, microorganism that can inhibit the growth or - reasonably priced. kill microorganisms. There is no ideal antimicrobic An antimicrobic or antimicrobial agent is Selective Toxicity - Drugs that specifically target a chemical substance similar to an microbial processes, and not the human host’s. antibiotic, but may be synthetic. Antibiotics Spectrum of antibiotics and targets • Naturally occurring antimicrobials – Metabolic products of bacteria and fungi – Reduce competition for nutrients and space • Bacteria – Streptomyces, Bacillus, • Molds – Penicillium, Cephalosporium * * 1 The mechanism of action for different 5 General Mechanisms of Action for antimicrobial drug targets in bacterial cells Antibiotics - Inhibition of Cell Wall Synthesis - Disruption of Cell Membrane Function - Inhibition of Protein Synthesis - Inhibition of Nucleic Acid Synthesis - Anti-metabolic activity Antibiotics
    [Show full text]
  • Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications
    International Journal of Molecular Sciences Review Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications Daniel Fernández-Villa 1, Maria Rosa Aguilar 1,2 and Luis Rojo 1,2,* 1 Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain; [email protected] (D.F.-V.); [email protected] (M.R.A.) 2 Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-915-622-900 Received: 18 September 2019; Accepted: 7 October 2019; Published: 9 October 2019 Abstract: Bacterial, protozoan and other microbial infections share an accelerated metabolic rate. In order to ensure a proper functioning of cell replication and proteins and nucleic acids synthesis processes, folate metabolism rate is also increased in these cases. For this reason, folic acid antagonists have been used since their discovery to treat different kinds of microbial infections, taking advantage of this metabolic difference when compared with human cells. However, resistances to these compounds have emerged since then and only combined therapies are currently used in clinic. In addition, some of these compounds have been found to have an immunomodulatory behavior that allows clinicians using them as anti-inflammatory or immunosuppressive drugs. Therefore, the aim of this review is to provide an updated state-of-the-art on the use of antifolates as antibacterial and immunomodulating agents in the clinical setting, as well as to present their action mechanisms and currently investigated biomedical applications. Keywords: folic acid antagonists; antifolates; antibiotics; antibacterials; immunomodulation; sulfonamides; antimalarial 1.
    [Show full text]
  • Unexpected Induction of Resistant Pseudomonas Aeruginosa Biofilm to fluoroquinolones by Diltiazem: a New Perspective of Microbiological Drug—Drug Interactionଝ
    Journal of Infection and Public Health (2008) 1, 105—112 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Unexpected induction of resistant Pseudomonas aeruginosa biofilm to fluoroquinolones by diltiazem: A new perspective of microbiological drug—drug interactionଝ Walid F. ElKhatib, Virginia L. Haynes, Ayman M. Noreddin ∗ University of Minnesota, Duluth, College of Pharmacy, Pharmacy Practice and Pharmaceutical Sciences, 1110 Kirby Dr. Life Sciences 232, Duluth, MN 55812, USA Received 15 August 2008; received in revised form 21 October 2008; accepted 22 October 2008 KEYWORDS Summary The increase of multi-drug resistant Pseudomonas aeruginosa infec- Diltiazem; tions is a worldwide dilemma. At the heart of the problem is the inability to treat Pseudomonas established P. aeruginosa biofilms with standard antibiotic therapy, including flu- aeruginosa; oroquinolones. We address a previously unstudied question as to the effect of a Biofilm; commonly prescribed calcium channel blocker (CCB) diltiazem on the biofilm growth. Resistance; Real-time monitoring of the overall growth and killing of P.aeruginosa biofilm during fluoroquinolones therapy in the presence and absence of diltiazem was performed. Fluoroquinolone In this study, we demonstrate that for P. aeruginosa biofilms, resistance to the first- line fluoroquinolones may be induced by the commonly prescribed calcium channel blocker diltiazem. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. All rights reserved. Introduction approved for the treatment of angina, hyper- tension and cardiac arrhythmia [1]. It acts as Diltiazem is a class III calcium channel blocker a calcium antagonist that controls calcium ion (CCB) belonging to benzothiazepines and has been influx in cardiac and vascular smooth muscle cells through slow voltage-gated L-type channels in the ଝ This manuscript was presented in part at the Design of Med- cell membrane.
    [Show full text]
  • A Família Asteraceae Bercht. & J. Preslem Afloramentos Rochosos Da
    Renalle Ruana Pessoa Ramos A FAMÍLIA ASTERACEAE BERCHT. & J. PRESL EM AFLORAMENTOS ROCHOSOS DA CAATINGA PARAIBANA: MORFOLOGIA, RIQUEZA E DISTRIBUIÇÃO Campina Grande – PB Fevereiro de 2011 Renalle Ruana Pessoa Ramos A FAMÍLIA ASTERACEAE BERCHT. & J. PRESL EM AFLORAMENTOS ROCHOSOS DA CAATINGA PARAIBANA: MORFOLOGIA, RIQUEZA E DISTRIBUIÇÃO Trabalho de Conclusão de Curso desenvolvido na área de Sistemática e Taxonomia de Fanerógamas apresentado à Universidade Estadual da Paraíba como exigência para a obtenção do grau de Bacharel em Ciências Biológicas. Orientador: José Iranildo Miranda de Melo Campina Grande – PB Fevereiro de 2011 F ICHA CATALOGRÁFICA ELABORADA PELA BIBLIOTECA CENTRAL – UEPB R175f Ramos, Renalle Ruana Pessoa. A Família Asteraceae Bercht. & J. Presl em afloramentos rochosos da caatinga paraibana [manuscrito]: riqueza, morfologia e distribuição. / Renalle Ruana Pessoa Ramos. – 2011. 141 f.: il. color. Digitado. Trabalho de Conclusão de Curso (Graduação em Ciências Biológicas) – Universidade Estadual da Paraíba, Centro de Ciências Biológicas e da Saúde, 2011. “Orientação: Prof. Dr. José Iranildo Miranda de Melo, Departamento de Biologia”. 1. Biologia Vegetal. 2. Flora Paraibana. 3. Botânica. 4. Morfologia floral. I. Título. 21. ed. 581.7 Renalle Ruana Pessoa Ramos A Família Asteraceae Bercht. & J. Presl em Afloramentos Rochosos da Caatinga Paraibana: Morfologia, Riqueza e Distribuição Trabalho de Conclusão de Curso desenvolvido na área de Sistemática e Taxonomia de Fanerógamas apresentado à Universidade Estadual da Paraíba como
    [Show full text]
  • Antimicrobial Chemotherapy and Sustainable Development: the Past, the Current Trend, and the Future
    African Journal of Biomedical Research, Vol. 11 (2008); 235 - 250 ISSN 1119 – 5096 © Ibadan Biomedical Communications Group Review Article Antimicrobial chemotherapy and Sustainable Development: The past, The Current Trend, and the future *1 2 3 3 Okonko I.O, Fajobi E.A, Ogunnusi T.A, Ogunjobi A.A. and 3Obiogbolu C.H. Full-text available at http://www.ajbrui.com 1Department of Virology, Faculty of Basic Medical Sciences, College of Medicine, http://www.bioline.br/md http://www.ajol.com University of Ibadan, University College Hospital (UCH), Ibadan, Nigeria 2 Department of Basic Sciences, Federal College of Wildlife Management, New Bussa, Niger State, Nigeria 4Microbiology Unit, Department of Botany and Microbiology, University of Ibadan, Ibadan ABSTRACT Antimicrobial chemotherapy is a highly valued medical science which has shaped modern humanity in a phenomenal fashion. Within the past half century, a wide variety of antimicrobial substances have been discovered, designed and synthesized; literally hundreds of drugs have been successfully used in some fashion over the years. Today, the world wide anti-infective market exceeds $20 billion dollars annually and overall antimicrobial agents comprise the bulk of this trade. A number of general classes of antimicrobial drugs have emerged as Received: mainstays in modern infectious disease chemotherapy. Regardless of a better August 2007 understanding of infectious disease pathogenesis and the importance of sanitation, most individuals will become infected with a microbial pathogen many times, Accepted (Revised): throughout their lives and in developed countries, anti-infective chemotherapy July 2008 will be periodically administered. Antibacterial amount for the majority of anti- infective agents in comparison to antifungals, antivirals and antiparasitic agents.
    [Show full text]
  • The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease
    International Journal of Molecular Sciences Review The Use of Antimicrobial and Antiviral Drugs in Alzheimer’s Disease Umar H. Iqbal, Emma Zeng and Giulio M. Pasinetti * Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; [email protected] (U.H.I.); [email protected] (E.Z.) * Correspondence: [email protected]; Tel.: +1-212-241-7938 Received: 29 May 2020; Accepted: 10 July 2020; Published: 12 July 2020 Abstract: The aggregation and accumulation of amyloid-β plaques and tau proteins in the brain have been central characteristics in the pathophysiology of Alzheimer’s disease (AD), making them the focus of most of the research exploring potential therapeutics for this neurodegenerative disease. With success in interventions aimed at depleting amyloid-β peptides being limited at best, a greater understanding of the physiological role of amyloid-β peptides is needed. The development of amyloid-β plaques has been determined to occur 10–20 years prior to AD symptom manifestation, hence earlier interventions might be necessary to address presymptomatic AD. Furthermore, recent studies have suggested that amyloid-β peptides may play a role in innate immunity as an antimicrobial peptide. These findings, coupled with the evidence of pathogens such as viruses and bacteria in AD brains, suggests that the buildup of amyloid-β plaques could be a response to the presence of viruses and bacteria. This has led to the foundation of the antimicrobial hypothesis for AD. The present review will highlight the current understanding of amyloid-β, and the role of bacteria and viruses in AD, and will also explore the therapeutic potential of antimicrobial and antiviral drugs in Alzheimer’s disease.
    [Show full text]
  • Antimicrobial Treatment Guidelines for Common Infections
    Antimicrobial Treatment Guidelines for Common Infections June 2016 Published by: The NB Provincial Health Authorities Anti-infective Stewardship Committee under the direction of the Drugs and Therapeutics Committee Introduction: These clinical guidelines have been developed or endorsed by the NB Provincial Health Authorities Anti-infective Stewardship Committee and its Working Group, a sub- committee of the New Brunswick Drugs and Therapeutics Committee. Local antibiotic resistance patterns and input from local infectious disease specialists, medical microbiologists, pharmacists and other physician specialists were considered in their development. These guidelines provide general recommendations for appropriate antibiotic use in specific infectious diseases and are not a substitute for clinical judgment. Website Links For Horizon Physicians and Staff: http://skyline/patientcare/antimicrobial For Vitalité Physicians and Staff: http://boulevard/FR/patientcare/antimicrobial To contact us: [email protected] When prescribing antimicrobials: Carefully consider if an antimicrobial is truly warranted in the given clinical situation Consult local antibiograms when selecting empiric therapy Include a documented indication, appropriate dose, route and the planned duration of therapy in all antimicrobial drug orders Obtain microbiological cultures before the administration of antibiotics (when possible) Reassess therapy after 24-72 hours to determine if antibiotic therapy is still warranted or effective for the given organism or
    [Show full text]
  • History of Antimicrobial Agents and Resistant Bacteria
    Research and Reviews History of Antimicrobial Agents and Resistant Bacteria JMAJ 52(2): 103–108, 2009 Tomoo SAGA,*1 Keizo YAMAGUCHI*2 Abstract Antimicrobial chemotherapy has conferred huge benefits on human health. A variety of microorganisms were elucidated to cause infectious diseases in the latter half of the 19th century. Thereafter, antimicrobial chemo- therapy made remarkable advances during the 20th century, resulting in the overly optimistic view that infectious diseases would be conquered in the near future. However, in response to the development of antimicrobial agents, microorganisms that have acquired resistance to drugs through a variety of mechanisms have emerged and continue to plague human beings. In Japan, as in other countries, infectious diseases caused by drug- resistant bacteria are one of the most important problems in daily clinical practice. In the current situation, where multidrug-resistant bacteria have spread widely, options for treatment with antimicrobial agents are limited, and the number of brand new drugs placed on the market is decreasing. Since drug-resistant bacteria have been selected by the use of antimicrobial drugs, the proper use of currently available antimicrobial drugs, as well as efforts to minimize the transmission and spread of resistant bacteria through appropriate infection control, would be the first step in resolving the issue of resistant organisms. Key words Antimicrobial agents, Resistant bacteria, History not achieve beneficial effect, and moreover, Introduction may lead to a worse prognosis. In addition, in a situation where multidrug-resistant organisms Antimicrobial drugs have caused a dramatic have spread widely, there may be quite a limited change not only of the treatment of infectious choice of agents for antimicrobial therapy.
    [Show full text]
  • Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R
    AMERICAN THORACIC SOCIETY DOCUMENTS Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori, Giovanni Sotgiu, Graham H. Bothamley, Jan L. Brozek, Adithya Cattamanchi, J. Peter Cegielski, Lisa Chen, Charles L. Daley, Tracy L. Dalton, Raquel Duarte, Federica Fregonese, C. Robert Horsburgh, Jr., Faiz Ahmad Khan, Fayez Kheir, Zhiyi Lan, Alfred Lardizabal, Michael Lauzardo, Joan M. Mangan, Suzanne M. Marks, Lindsay McKenna, Dick Menzies, Carole D. Mitnick, Diana M. Nilsen, Farah Parvez, Charles A. Peloquin, Ann Raftery, H. Simon Schaaf, Neha S. Shah, Jeffrey R. Starke, John W. Wilson, Jonathan M. Wortham, Terence Chorba, and Barbara Seaworth; on behalf of the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America THIS OFFICIAL CLINICAL PRACTICE GUIDELINE WAS APPROVED BY THE AMERICAN THORACIC SOCIETY, THE EUROPEAN RESPIRATORY SOCIETY, AND THE INFECTIOUS DISEASES SOCIETY OF AMERICA SEPTEMBER 2019, AND WAS CLEARED BY THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION SEPTEMBER 2019 Background: The American Thoracic Society, U.S. Centers for was judged to be very low, because the data came Disease Control and Prevention, European Respiratory Society, and from observational studies with significant loss to follow-up Infectious Diseases Society of America jointly sponsored this new and imbalance in background regimens between comparator practice guideline on the treatment of drug-resistant tuberculosis groups. Good practices in the management of MDR-TB are (DR-TB). The document includes recommendations on the described. On the basis of the evidence review, a clinical strategy treatment of multidrug-resistant TB (MDR-TB) as well as tool for building a treatment regimen for MDR-TB is also isoniazid-resistant but rifampin-susceptible TB.
    [Show full text]
  • The Role of Vaccines in Combatting Antimicrobial Resistance
    REVIEWS The role of vaccines in combatting antimicrobial resistance Francesca Micoli1, Fabio Bagnoli2, Rino Rappuoli 2 ✉ and Davide Serruto2 Abstract | The use of antibiotics has enabled the successful treatment of bacterial infections, saving the lives and improving the health of many patients worldwide. However, the emergence and spread of antimicrobial resistance (AMR) has been highlighted as a global threat by different health organizations, and pathogens resistant to antimicrobials cause substantial morbidity and death. As resistance to multiple drugs increases, novel and effective therapies as well as prevention strategies are needed. In this Review, we discuss evidence that vaccines can have a major role in fighting AMR. Vaccines are used prophylactically, decreasing the number of infectious disease cases, and thus antibiotic use and the emergence and spread of AMR. We also describe the current state of development of vaccines against resistant bacterial pathogens that cause a substantial disease burden both in high-income countries and in low- and medium-income countries, discuss possible obstacles that hinder progress in vaccine development and speculate on the impact of next-generation vaccines against bacterial infectious diseases on AMR. The use of antimicrobials has enabled the treatment of antibiotics, diagnostic tools, monoclonal antibodies, potentially life-threatening infections, saving the lives microbiota interventions and the use of bacteriophages and improving the health of many patients worldwide. is required to combat AMR effectively (BOx 1). However, the increasing number and global distribu- Vaccines have an unprecedented impact on human tion of drug-resistant pathogens is one of the major health7 and can be used for decades with a much lower health challenges, compromising the ability to prevent probability of resistance emergence compared with and cure a wide range of infectious diseases that were antibiotics8.
    [Show full text]
  • Antimicrobial Therapy of Pulmonary Tuberculosis *
    Bull. Org. mond. Sante 1960, 23 427-461 Bull. Wld Hlth Org. Antimicrobial Therapy of Pulmonary Tuberculosis * WALSH McDERMOTT, M.D.' The discovery, some nine years ago, ofthe highly specific antituberculous drug, isoniazid, marked an important advance in the antimicrobial therapy of tuberculosis, first practised successfully with streptomycin and p-aminosalicylic acid (PAS) in the late 'forties. Isoniazid is relatively non-toxic and, unlike streptomycin, can be administered orally, so that it is eminently suitable for use, either alone or in combination with PAS, in the domi- ciliary treatment of tuberculous patients. The wisdom of employing it on a large scale in home-treatment programmes, however, has been questioned on the ground that such wide- spread use might result in a spread of tubercle bacilli resistant to the drug. This contro- versial subject is discussed in some detail in this general review of the chemotherapy of tuberculosis. The author is convinced that, so far, the benefits of isoniazid therapy have outweighed the disadvantages and, though well aware of the possible consequences in terms of isoniazid-resistance, sees no reason at the present time for not making full use of this valuable weapon in the antituberculosis armamentarium. INTRODUCTION It is now approximately fifteen years since the first mena that had already been quite well established successful demonstration of the antimicrobial from the chemotherapy of other infections. One therapy of tuberculosis and it is highly appropriate can always find fault with what is going on around that we take stock of the situation at this time. The one, however, and despite these annoyances things fifteen-year period has been one of great achieve- have, on the whole, certainly progressed very well.
    [Show full text]
  • In Chile 61 Doi: 10.3897/Phytokeys.161.53736 RESEARCH ARTICLE Launched to Accelerate Biodiversity Research
    A peer-reviewed open-access journal PhytoKeys 161: 61–77 (2020) Ophryosporus in Chile 61 doi: 10.3897/phytokeys.161.53736 RESEARCH ARTICLE http://phytokeys.pensoft.net Launched to accelerate biodiversity research Notes on the genus Ophryosporus (Asteraceae, Eupatorieae) in Chile Felix F. Merklinger1, Federico Luebert1,2 1 University of Bonn, Nees Institute for Biodiversity of Plants, Meckenheimer Allee 170, D–53115 Bonn, Germany 2 Departmento de Silvicultura y Conservación de la Naturaleza, Universidad de Chile, Av. Santa Rosa 11315, Santiago, Chile Corresponding author: Felix F. Merklinger ([email protected]) Academic editor: Y. Mutafchiev | Received 28 April 2020 | Accepted 21 August 2020 | Published 15 September 2020 Citation: Merklinger FF, Luebert F (2020) Notes on the genus Ophryosporus (Asteraceae, Eupatorieae) in Chile. PhytoKeys 161: 61–77. https://doi.org/10.3897/phytokeys.161.53736 Abstract Ophryosporus Meyen is reviewed for Chile and an updated species list for the country based on herbarium records and literature review is presented. A key to the Chilean species is provided and a distribution range of taxa is indicated based on herbarium records and our own collections. We include several lectotypi- fications as well as an epitypification ofOphryosporus hoppii. The presence of two species,O. hoppii and O. floribundus, formerly accepted for Chile, is questioned and their actual distribution discussed. Resumen Se revisa el género Ophryosporus para Chile y se presenta una lista actualizada de especies para el país basada en registros de herbario y una revisión de la literatura. Se proporciona una clave para las especies chilenas y se indica el rango de distribución de los taxones basado en registros de herbario.
    [Show full text]